 |
|
|
| |
Sofosbuvir/Velpatasvir Single Tablet Regimen in HCV Monoinfected and HIV/HCV Coinfected Patients: Comparison of Efficacy and Safety Data from Phase 3 Clinical Trials
|
| |
| |
Reported by Jules Levin
HIV Glasgow Oct 23-26 2016
D Wyles,1 N Brau,2 S Naggie,3 M Sulkowski,4 K Agarwal,5 K Patel,6 N Afdhal,7 L Liu,8 X Ding,8 KC Huang,8 A Osinusi,9 J McNally,9 DM Brainard,9 M Mertens,10 JG McHutchison,9
1University of California Division of Infectious Diseases San Diego United States of America; 2James J. Peters VA Medical Center Department of Medicine, Icahn School of Medicine New York United States of America; 3Duke Clinical Research Institute Duke University Medical Center Durham United States of America; 4Johns Hopkins University School of Medicine Viral Hepatitis Center Baltimore United States of America; 5Kings College Hospital Institute of Liver Studies London United Kingdom; 6Duke University Medical Center Division of Gastroenterology Durham United States of America; 7Beth Israel Deaconess Medical Center Hepatology Boston United States of America; 8Gilead Sciences Biostatistics Foster City United States of America; 9Gilead Sciences Clinical Research Foster City United States of America; 10Gilead Sciences Medical Affairs London United Kingdom
|
| |
|
|
|
|
|
